Apiam Animal Health has secured court approval for its corporate scheme, paving the way for a fully franked special dividend payment next month.
- Supreme Court of NSW approves corporate Scheme
- Scheme legally effective as of 6 February 2026
- Fully franked special dividend of AUD 0.10 per share declared
- Dividend payment scheduled for 16 February 2026
- Dividend Reinvestment Plan suspended for this payment
Court Approval Finalises Scheme
Apiam Animal Health Limited (ASX – AHX) has announced a significant regulatory milestone with the Supreme Court of New South Wales granting approval for its corporate Scheme on 6 February 2026. This approval, now lodged with the Australian Securities and Investments Commission, renders the Scheme legally effective, marking a key step in the company’s strategic agenda.
Special Dividend Declared
Following the court’s endorsement, Apiam has declared a special dividend of AUD 0.10 per fully paid ordinary share. This dividend is fully franked, reflecting the company’s strong tax position and commitment to returning value to shareholders. The dividend will be paid on 16 February 2026, with the record date set for 13 February and the ex-dividend date on 12 February.
Dividend Reinvestment Plan Suspended
Notably, the company has suspended its Dividend Reinvestment Plan (DRP) for this special dividend. This means shareholders will receive the dividend in cash rather than having the option to reinvest in additional shares. The suspension of the DRP could indicate a strategic preference for liquidity distribution over equity issuance at this juncture.
Implications for Shareholders and Market
The approval of the Scheme and the accompanying special dividend signal a positive development for shareholders, offering immediate tangible returns. However, the announcement leaves open questions about the broader impact of the Scheme on Apiam’s long-term operational and financial strategy. Investors will be watching closely for subsequent updates on how this corporate restructuring aligns with growth prospects and capital management policies.
Bottom Line?
With the Scheme now effective and a special dividend imminent, Apiam’s next moves will be closely scrutinised by the market.
Questions in the middle?
- What are the long-term strategic goals behind the approved Scheme?
- Will the Dividend Reinvestment Plan remain suspended for future dividends?
- How will the Scheme affect Apiam’s operational performance and growth trajectory?